MedPath

Evaluation of the Efficacy of Dissociation-Focused Cognitive Behavior Therapy: a Multicenter Randomized Controlled Trial

Not Applicable
Not yet recruiting
Conditions
Dissociative Disorder
Registration Number
NCT06917209
Lead Sponsor
University Hospital, Tours
Brief Summary

Dissociative symptoms and disorders are particularly prevalent in the general population and among people suffering from psychiatric disorders. To date, no treatment has proven effective for this type of problem. Exploratory studies (without control group) have been carried out. Among these studies, dissociation-focused cognitive behavioral therapy (DF-CBT) seems promising. DF-CBT is based on a solid empirical model that has received numerous scientific evidence.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
140
Inclusion Criteria
  • ≥ 18 years
  • Membership of a social security scheme
  • Participant's express consent
  • Have at least one diagnosis of dissociative disorder among the following:

depersonalization/derealization disorder, dissociative identity disorder, unspecified dissociative disorder.

  • Be able to carry out psychotherapy sessions.
  • If taking psychiatric medication, treatment must have been stable for at least 30 days.
Exclusion Criteria
  • Present one of the following current diagnoses: substance use disorder (excluding tobacco), neurodevelopmental disorder, anorexia nervosa, severe depressive disorder, schizophrenia spectrum disorder, bipolar disorder, personality disorder other than borderline personality disorder.
  • Present cognitive deficits.
  • Be engaged in psychotherapeutic work.
  • Be undergoing benzodiazepine treatment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Difference in Dissociative Experience Scale (DES)Between randomization and 3 months after

Difference in Dissociative Experience Scale (DES) between randomization and 3 months after.

The DES assesses dissociation through 28 items. The total score ranges between 0 and 100, where high scores indicate high levels of dissociation.

Secondary Outcome Measures
NameTimeMethod
Hetero-administered visual analogue scaleAt randomization, 3 months and 6 months after

Visual analogue scales in which the practitioner rates the intensity of the patient's dissociative symptoms on the basis of his/her clinical assessment.

Dissociative Experiences Scale (DES)At 6 months after randomization

The DES assesses dissociation through 28 items. The total score ranges between 0 and 100, where high scores indicate high levels of dissociation.

Hospital Anxiety Depression Scale (HADS)Randomization, 3 months and 6 months after

Hospital Anxiety Depression Scale (HADS) is a 14-item self-report questionnaire. Two sub-scores (anxiety and depression) are calculating.

Both scores range between 0 and 21 with 0 corresponding to the ideal score (no anxiety or depression symptoms).

Dissociation Questionnaire (DIS-Q)At randomisation, 3 months and 6 months after

The Dissociation Questionnaire is a 63-item questionnaire measuring dissociative-trait manifestations. Participants respond to each item using a 5-point Likert scale. Four sub-scores (loss of control, absorption, amnesia and identity confusion) are calculated.

Post traumatic stress disorder checklist scale (PCL-5)Randomization, 3 months and 6 months after

The post traumatic stress disorder checklist scale (PLC-5) is 20-item scale to assess post-traumatic stress symptoms. Participants respond to each item using a 5-point Likert scale. The score ranges between 0 and 80, with 0 reflecting no post traumatic stress disorder.

Satisfaction With Life Scale (SWLS)Randomization, 3 months and 6 months after

The Satisfaction With Life Scale (SWLS) is a 5-item questionnaire assessing quality of life. Participants respond to each item using a 7-point Likert scale. The score range bewteen 0 and 35 with 35 reflects an extreme satisfaction with life.

© Copyright 2025. All Rights Reserved by MedPath